Skip to main content

Quadcap Wealth Management, LLC

Position in VKTX — Viking Therapeutics, Inc.

CIK 2009674 Frisco, TX

Position in VKTX

as of Jun 30, 2026 · filed Jul 31, 2026
Position Value
$224,619
+$4,183 QoQ
Shares Held
5,758
-31.4% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#292
of 434 holders
Holding Since
Mar 2024
8 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in VKTX Over Time

Shares Held

Position Value (USD)

Derivatives in VKTX

reported options exposure · as of Mar 31, 2025
CallValue
$16,905
CallShares
700
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Quadcap Wealth Management, LLC holds $2,649,115 across 9 Biotechnology names. VKTX ranks #5 (8.5% of the industry book) .

# Ticker Company Shares Value (USD) Open
5 VKTX
Viking Therapeutics, Inc.
This page
5,758 $224,619

All Filings in VKTX

Export CSV
11 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $224,619 5,758
2025-09-30 $220,436 8,388
2025-06-30 $279,257 10,538
2025-03-31 $16,905 700
2025-03-31 $221,962 9,191
2024-12-31 $20,120 500
2024-12-31 $363,005 9,021
2024-09-30 $628,541 9,928
2024-06-30 $5,301 100
2024-06-30 $527,396 9,949
2024-03-31 $455,182 5,551